Enrofloxacin is a fluoroquinolone synthetic antibiotic and quinolone carboxylic acid derivative, belonging to the 6-fluoro-7-piperazinyl-4-quinolones. A broad-spectrum antibiotic, it targets Gram-positive and Gram-negative bacteria along with a few Mycoplasma species. It is a chemotherapeutic, and was first synthesized in 1983 from nalidixic acid, and the first enrofloxacin-based therapeutic compound landed on the market in 1991 as an oral formulation for poultry under the trade name Baytril® (Bayer). It can be used to investigate bacterial genetics and study the mode of action of fluoroquinolones.
Enrofloxcin is slightly soluble in aqueous solution.
We also offer:
- Enrofloxacin Hydrochloride (E007)